RT @synovialjoints: JAK and TYK-2 inhibitors and indications in SpA: â Tofacitinib ⣠Pan JAKi (AS, PsA) â Baricit
Tweet Content
JAK and TYK-2 inhibitors and indications in SpA:
● Tofacitinib ➣ Pan JAKi (AS, PsA)
● Baricitinib ➣ JAK1,2
● Upadacitinib ➣ JAK1 (AxSpA, PsA)
● Deucravacitinib ➣ TYK2 (PsA)
Carol Langford, Year in Review #ACR22 @RheumNow https://t.co/EMLEvptySS
Show on Archive Page
On
Display in Search Results
On
PDQ
Off